Breaks Categories: News

ThursdayOct 24, 2024 11:10 am

NetworkNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Offshoot McEwen Copper Secures Additional $35 Million Investment from Rio Tinto’s Nuton

McEwen Mining (NYSE: MUX) (TSX: MUX) subsidiary McEwen Copper has secured an additional $35 million investment from Nuton LLC, a Rio Tinto Venture, as part of its ongoing private placement financing. This second tranche brings the total raised to $56 million, with Nuton now owning 17.2% of McEwen Copper. The funds will support the development of the Los Azules copper project, with a feasibility study expected by mid-2025. McEwen Copper’s post-money market value is now $984 million, with major shareholders including McEwen Mining, Stellantis, Nuton, and Rob McEwen. To view the full press release, visit https://nnw.fm/sqSll About McEwen Mining Inc.…

Continue Reading

ThursdayOct 24, 2024 10:23 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures $3 Million in Registered Direct Offering

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company focused on developing treatments for cancers affecting the brain and central nervous system, has announced that it has entered into securities purchase agreements with institutional investors to raise approximately $3 million. The funding will come from the sale of 17,647,060 shares of common stock, priced at $0.17 per share, in a registered direct offering. The proceeds will be used for general corporate purposes and working capital. A.G.P./Alliance Global Partners is acting as the sole placement agent for the transaction, which is expected to close today, Oct. 24, 2024, pending customary conditions. To view…

Continue Reading

ThursdayOct 24, 2024 9:00 am

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Wins 2024 Digital Health Hub Award for Innovation in Cardiac Care

HeartBeam (NASDAQ: BEAT), a medical technology company focused on advancing cardiac care, was recognized with the 2024 Digital Health Hub Rising Star award in the ‘Home Health Diagnostic’ category at the HLTH global healthcare conference. The award highlights HeartBeam’s innovative vector-based technology, which captures heart electrical signals in three dimensions to provide detailed cardiac insights. CEO Rob Eno emphasized the importance of timely care in cardiac health, praising the team’s efforts in developing a cable-free, credit card-sized ECG device, currently under FDA review, as a step towards personalized, AI-driven cardiac care. To view the full press release, visit https://nnw.fm/hj8eL About…

Continue Reading

WednesdayOct 23, 2024 12:02 pm

NetworkNewsBreaks – Match Group Inc. (NASDAQ: MTCH) to Discuss Q3 2024 Financial Results

  Match Group (NASDAQ: MTCH) is set to host a webcast conference call to discuss its third quarter 2024 financial results on November 7, 2024. Known for its popular dating platforms like Tinder, Hinge and OkCupid, Match Group operates in over 40 languages, catering to a global audience. The company will release its financial results and investor materials on November 6, 2024. Match Group’s financial metrics provide insight into its market valuation. With a price-to-earnings (“P/E”) ratio of 15.26, the market values its earnings moderately. This ratio helps investors understand how much they are paying for each dollar of earnings.…

Continue Reading

TuesdayOct 22, 2024 1:15 pm

NetworkNewsBreaks – EF Hutton Serves as Placement Agent to Humacyte Inc.’s (NASDAQ: HUMA) $30M RDO

EF Hutton announced that it served as exclusive placement agent to Humacyte (NASDAQ: HUMA) in connection with its $30 million registered direct offering. Earlier this month, Humacyte announced its entry into a securities purchase agreement with an institutional investor to purchase approximately $30.0 million worth of its common stock and warrants in the registered direct offering. Under the terms of the agreement, the company agreed to sell 5,681,820 shares of its common stock and warrants to purchase 5,681,820 shares of common stock. To view the full press release, visit https://nnw.fm/QAVzH About Humacyte Inc. Humacyte is developing a disruptive biotechnology platform…

Continue Reading

TuesdayOct 22, 2024 12:31 pm

NetworkNewsBreaks – Alphabet Inc. (NASDAQ: GOOGL) Partners with Honeywell

Honeywell, a leading player in the industrial sector, is partnering with Alphabet’s (NASDAQ: GOOGL, GOOG) Google to integrate Google’s Gemini generative AI with its vast data resources. This collaboration, starting in 2025, aims to improve efficiency by reducing maintenance times and increasing productivity. Honeywell’s move comes as the industrial sector faces a labor crisis, which this partnership seeks to address. Alphabet has a price-to-earnings (“P/E”) ratio of 23.21, showing investor confidence in its earnings potential. This partnership with Honeywell could further enhance Alphabet’s market position by leveraging its AI capabilities in the industrial sector. Alphabet’s price-to-sales ratio of 6.21 and…

Continue Reading

TuesdayOct 22, 2024 11:56 am

NetworkNewsBreaks – SOBRsafe Inc. (NASDAQ: SOBR) Launches Enterprise Software for Alcohol Compliance Monitoring

SOBRsafe (NASDAQ: SOBR) has introduced an enterprise software platform that integrates its transdermal alcohol detection technologies, SOBRcheck and SOBRsure, into a streamlined dashboard for health providers. The system allows real-time monitoring of alcohol compliance across multiple users and locations, addressing inefficiencies in current testing methods. By offering instant, non-invasive detection of alcohol through the skin, the software aims to enhance treatment outcomes and improve organizational efficiency in behavioral health centers. The platform's historical data tracking also aids compliance verification with third parties. To view the full press release, visit https://nnw.fm/PCiuT About SOBRsafe(TM) Alcohol misuse is the fourth leading cause of…

Continue Reading

TuesdayOct 22, 2024 11:25 am

NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) to Present Key Alzheimer’s Research at CTAD Conference in Madrid

Annovis Bio (NYSE: ANVS) will showcase its latest scientific findings on its Alzheimer’s drug candidate, Buntanetap, at the 17th Clinical Trials on Alzheimer’s Disease (“CTAD”) conference in Madrid from Oct. 29 to Nov. 1, 2024. The company will present two posters highlighting Buntanetap’s efficacy in early Alzheimer’s patients and its impact on reducing neurotoxic proteins, improving axonal integrity, and enhancing neuronal function. These results further support Annovis Bio's ongoing efforts to develop transformative therapies for neurodegenerative diseases. To view the full press release, visit https://nnw.fm/ME3ma About Annovis Bio Inc. Annovis Bio, headquartered in Malvern, Pennsylvania, is committed to addressing neurodegeneration…

Continue Reading

TuesdayOct 22, 2024 10:45 am

NetworkNewsBreaks – Tuttle Capital Management Launches Select STOXX Europe Aerospace & Defense ETF

Tuttle Capital Management has introduced the Select STOXX Europe Aerospace & Defense ETF (EUAD), which will begin trading today. The fund invests at least 80% of its assets in companies within the STOXX® Europe Total Market Aerospace & Defense Index, focusing on European-based companies that derive over 50% of their revenue from aerospace and defense sectors. CEO Matthew Tuttle highlights the fund's strategic potential, noting the investment opportunity driven by global tensions and potential shifts in U.S. security commitments to Europe. To view the full press release, visit https://nnw.fm/U3xSe About Tuttle Capital Management TCM believes it is an industry leader…

Continue Reading

TuesdayOct 22, 2024 9:30 am

NetworkNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Secures Initial C$1.38 Million in Funding for Storm Copper Project Joint Venture

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) has received an initial US$1 million (C$1.38M) as part of a $12.5 million funding agreement with American West Metals and Taurus Mining Royalty Fund. The funding will support the exploration and development of the Storm Copper Project in Nunavut, with future payments contingent on project milestones, including the completion of a prefeasibility study and resource upgrades. Aston Bay holds a 20% interest in the project and will use its share of the funds to advance other exploration activities. To view the full press release, visit https://nnw.fm/EXgOY About Aston Bay Holdings Ltd. Aston Bay is…

Continue Reading